Form 4: Lexaria Bioscience Corp. CFO Acquires 50,000 Stock Options
SEC Form 4 Filing
Michael Shankman, CFO of Lexaria Bioscience Corp., reports the acquisition of 50,000 stock options with an exercise price of $1.04.
Summary
- Michael Shankman, the Chief Financial Officer of Lexaria Bioscience Corp., filed a Form 4.
- The form reports the acquisition of 50,000 stock options on May 15, 2025.
- These options have an exercise price of $1.04 and expire on May 15, 2030.
- Following this transaction, Shankman directly owns 100,000 stock options.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock option grants, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock option grants, common in publicly traded companies.
Stakeholder Impact
- The granting of stock options to the CFO aligns his interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | 20,000 options are exercisable |
| 05/15/2025 | Date of transaction: Acquisition of 50,000 stock options at $1.04 exercise price; 50,000 options are exercisable |
| 05/16/2025 | Date of Form 4 filing |
| 08/31/2025 | An additional 15,000 options are exercisable |
| 08/31/2026 | The remaining 15,000 options are exercisable |
| 10/01/2029 | Expiration date for 50,000 stock options with an exercise price of $3.17 |
| 05/15/2030 | Expiration date for 50,000 stock options with an exercise price of $1.04 |
Keywords
Form 4, Stock Options, Michael Shankman, Lexaria Bioscience Corp., LEXX, CFO, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.